Flexion Therapeutics to Present at the Needham 20th Annual Virtual Healthcare Conference
Flexion Therapeutics (Nasdaq:FLXN) announced that Dr. Michael Clayman, the company's President and CEO, will engage in an analyst-led fireside chat during the Needham 20th Annual Healthcare Conference. This virtual event is set for 9:30 a.m. ET on April 15, 2021. Participants can access the live webcast through the Flexion Therapeutics website. The company is dedicated to developing novel therapies for musculoskeletal conditions such as osteoarthritis, highlighting its commitment to innovation and transparency.
- None.
- None.
BURLINGTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Needham 20th Annual Healthcare Conference. The virtual fireside chat is scheduled to begin at 9:30 a.m. ET on Thursday, April 15, 2021.
To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.
Contact:
Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com
FAQ
When is the analyst-led fireside chat for Flexion Therapeutics scheduled?
Who will represent Flexion Therapeutics in the Needham Healthcare Conference?
How can I access the Flexion Therapeutics fireside chat?
What is the main focus of Flexion Therapeutics?
What is the stock symbol for Flexion Therapeutics?
